Slideflow Labs develops AI biomarker tests that analyze standard H&E slides within a hospital's infrastructure and return quantitative tumor biology results in minutes.
A cancer pathology AI startup secures the first-place award at the 2026 Edward L. Kaplan, ’71, New Venture Challenge. The company receives $2.1 million in funding from judges and investors during the 30th annual event held on June 4. The competition supports early-stage ventures with innovative solutions in healthcare technology.
Techstars and Northwestern Medicine select five early-stage healthcare startups for the 2026 cohort of their healthcare accelerator. The three-month, mentorship-driven program is based in Chicago.
Polsky Center for Entrepreneurship and InnovationFeb 2025
Slideflow Labs aims to transform disease diagnostics through an AI-driven approach to biomarker discovery. The company brings together physician-scientists and technical experts to address significant challenges in pathology. Its stated goals are to improve patient outcomes and reduce healthcare costs.
Slideflow is a software package for deep learning in digital histopathology. It supports a broad array of deep learning methods for digital pathology and provides a fast whole-slide interface for deploying trained models.